Crossref
Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk
JAMA · 2024
DOI: 10.1001/jama.2024.5922 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Anticonvulsants, Autistic Disorder, Epilepsy, Prenatal Exposure Delayed Effects.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
AnticonvulsantsAutistic DisorderEpilepsyPrenatal Exposure Delayed EffectsValproic AcidChildFemaleHumansPregnancyPregnancy ComplicationsRiskTopiramateLamotrigine
Substanzen
AnticonvulsantsValproic AcidTopiramateLamotrigine
Zitieren
APA
Harris, E. (2024). Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk. JAMA. https://doi.org/10.1001/jama.2024.5922
Vancouver
Harris E. Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk. JAMA. 2024. doi:10.1001/jama.2024.5922
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Type of Prenatal Antiseizure Drug Matters for Children’s Autism Risk},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.5922}
}
EUVIMED